<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00625911</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-01-AW-114-CTIL</org_study_id>
    <nct_id>NCT00625911</nct_id>
  </id_info>
  <brief_title>Ketamine Improves Post-Thoracotomy Analgesia</brief_title>
  <official_title>Ketamine Improves Post-Thoracotomy Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thoracotomy for lung tumor or for minimally invasive direct coronary artery bypass (MIDCAB)
      surgery, may be associated with debilitating pain. Ketamine was shown to enhance opioid
      antinociception and prevent opioid resistance. We hypothesize that ketamine given with
      morphine would lower morphine consumption and narcotic related side effects after thoracotomy
      and provide superior analgesia to morphine given alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We planned a prospective, randomomized, double blind study of 2 pain management protocols in
      consecutive patients undergoing thoracotomy for MIDCAB or lung tumor resection over a 6 month
      period. After patients emerged from a standardized general anesthetic and when objectively
      awake and complaining of pain &gt;5/10 on a visual analogue pain scale, they were connected to
      an intravenous patient controlled analgesia regimen. The regimen was assigned randomly to be
      either morphine alone (1.5 mg per dose, lockout interval of 7 minutes) or morphine plus
      ketamine (1.0 mg morphine plus 5 mg ketamine per dose, same lockout interval). Rescue
      diclofenac was available to both groups. Follow-up lasted 4 hours.

      We planned to monitor and compare pain scores, wakefulness scores, hemodynamic and
      respiratory parameters as well as total morphine consumption and incidence of side effects
      and complications. All monitoring and recording was done by blinded nurses and intensive care
      physicians.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2001</start_date>
  <completion_date type="Actual">March 2002</completion_date>
  <primary_completion_date type="Actual">March 2002</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain score</measure>
    <time_frame>4 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>hemodynamic and respiratory parameters, side effects</measure>
    <time_frame>4 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Post Operative Pain</condition>
  <arm_group>
    <arm_group_label>morphine only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard analgesia protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>morphine ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>alterantive regimen for intravenous patient controlled analgesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>morphine</intervention_name>
    <description>intravenous patient controlled analgesia, standard protocol</description>
    <arm_group_label>morphine only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>morphine ketamine</intervention_name>
    <description>low dose ketamine added to 2/3 standard dose of morphine</description>
    <arm_group_label>morphine ketamine</arm_group_label>
    <other_name>ketalar</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive patients scheduled for elective minimally invasive direct coronary artery
             bypass (MIDCAB) or for lung resection via anterolateral thoracotomy during a 6-month
             period (Sep 2001-March 2002)

        Exclusion Criteria:

        Exclusion criteria were:

          -  American Society of Anesthesiologists (ASA) physical class â‰¥3, Emergency operations,

          -  Q-wave myocardial infarct occurring during the previous 3 weeks, or poor left
             ventricular function (e.g., ejection fraction [EF] &lt;30% by echocardiography or
             angiography).

        Other exclusion criteria were:

          -  A body mass index &gt;35 kg/m2,

          -  Past or current neuropathy or psychological disturbances,

          -  The use of centrally active drugs,

          -  Chronic liver or renal failure requiring dialysis,

          -  A FEV1/FVC &lt;70%,

          -  Allergy to ketamine, morphine or non steroidal anti inflammatory drugs (NSAIDs),

          -  Clotting abnormalities,

          -  A platelets count &lt;70000/mm3,

          -  A white blood count &lt;3000&gt;14000/mm3,

          -  Uncontrolled diabetes mellitus or fasting blood glucose &gt;250 g/dl,

          -  Evidence of sepsis or infection up to one week prior to randomization.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Avi A Weinbroum, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel-Aviv Sourasky Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64238</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2008</study_first_submitted>
  <study_first_submitted_qc>February 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 29, 2008</study_first_posted>
  <last_update_submitted>February 28, 2008</last_update_submitted>
  <last_update_submitted_qc>February 28, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 29, 2008</last_update_posted>
  <responsible_party>
    <name_title>Avi A Weinbroum, MD</name_title>
    <organization>Tel Aviv Sourasky Medical Center</organization>
  </responsible_party>
  <keyword>thoracotomy</keyword>
  <keyword>minimally invasive direct coronary artery bypass</keyword>
  <keyword>ketamine</keyword>
  <keyword>pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

